CompletedNot applicableNCT01117454

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

Studying Catecholaminergic polymorphic ventricular tachycardia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vanderbilt University Medical Center
Principal Investigator
Prince J Kannankeril, MD, MSCI, MD
Vanderbilt University
Intervention
Flecainide Acetate(drug)
Enrollment
14 enrolled
Eligibility
5-99 years · All sexes
Timeline
20112015

Study locations (10)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01117454 on ClinicalTrials.gov

Other trials for Catecholaminergic polymorphic ventricular tachycardia

Additional recruiting or active studies for the same condition.

See all trials for Catecholaminergic polymorphic ventricular tachycardia

← Back to all trials